Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
ANIX
Anixa Biosciences, Inc.
NASDAQCM
Biotechnology
United States
$3.07
▲
+0.02 (+0.66%)
CLOSED
—
OPEN
$3.03
HIGH
$3.10
LOW
$3.00
PREV CLOSE
$3.05
VOLUME
367.8K
1.35x avg
BID / ASK
2.22 / 3.08
spr 0.860
MARKET CAP
$104.5M
DAY RANGE
$3.00
$3.10
P/E (TTM)
—
Fwd -9.9
EPS (TTM)
-0.30
DIV YIELD
—
52W HIGH
$5.46
-43.8%
52W LOW
$2.32
+32.3%
BETA
0.52
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$3.31
+0.24
(+7.71%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
ANIX
$3.07
▲
+0.66%
Chart
Valuation
Financials
Peers
News
ANIX · K 線技術分析（即時、可互動）
basic
pro
快速分析（約半分鐘，最長 5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，通常約半分鐘，上游壅塞時最長 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
MIXED
252 BARS · +3.4% YOY
1-year price chart. Started at 2.97, currently 3.07, up 3.4 percent. Range 2.35 to 5.22 over 252 data points.
2025-09-05
$2.97 → $3.07 (+3.4%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
—
WACC Used
+7.0%
Terminal g
+3.5%
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers. · Comparables skipped: no peer multiples or no per-share economics from Finnhub metric endpoint.
FINANCIALS
多年財務（SEC XBRL）
—
4 FY · NO YOY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-10
—
-$10.9M
-$7.2M
—
$16.1M
2024-10
—
-$12.6M
-$7.3M
—
$21.6M
2023-10
$210.0K
-$9.8M
-$6.2M
—
$25.5M
2021-10
$512.0K
—
—
—
—
NEWS
近期新聞（過去 14 天）
CALM
10 HEADLINES · LAST 14 DAYS
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
PR Newswire · 2026-09-03
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
PR Newswire · 2026-08-24
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · 2026-08-18
Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know
Zacks · 2026-07-22
Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?
Zacks · 2026-07-22
New Strong Buy Stocks for July 22nd
Zacks · 2026-07-22
Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
PR Newswire · 2026-07-06
Anixa Biosciences secures Korean patent for breast cancer vaccine
Pharmaceutical Technology · 2026-06-30